ArticleHealth science reports2026
Prevalence of Serologic Weak D Phenotype in Iranian Blood Donors: A Nationwide Retrospective Cross-Sectional Study.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: The serologic prevalence of the Weak D phenotype varies across populations and may be influenced by laboratory methodology. However, nationwide data from Iran remain limited. This study aimed to determine the nationwide serologic prevalence of the Weak D phenotype among Iranian blood donors and to compare detection rates between manual and automated RhD typing methods. Methods: This nationwide retrospective cross-sectional study included 1,991,758 blood donors from all 31 provinces of Iran between December 2022 and December 2023. RhD typing was performed using either manual tube testing or automated platforms (Magnet and solid-phase red cell adherence [SPRCA]). Prevalence estimates with 95% confidence intervals (CIs) were calculated and compared using Results: Among 1,991,758 blood donors, 213,693 (10.72%) were Rh-negative. Serologic Weak D was identified in 1001 donors, corresponding to an overall prevalence of 0.0503% (95% CI: 0.0472-0.0535) and 0.4684% among Rh-negative donors. The prevalence was 0.0491% with manual testing and 0.0518% with automated testing, with no significant difference between the two methods ( Conclusion: The nationwide prevalence of serologically detected Weak D phenotype in Iranian blood donors was 0.0503%, placing Iran within the lower range of global estimates. Although no significant overall difference was observed between manual and automated RhD typing, the Solid Phase platform demonstrated significantly higher detection rates than the Magnet platform. These findings support standardized RhD typing strategies to improve diagnostic consistency and optimize transfusion safety at the national level.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.